معرفی
Evan A. Scott is the Kay Davis Professor of Biomedical Engineering and Microbiology-Immunology at Northwestern University's McCormick School of Engineering and Feinberg School of Medicine. He holds dual appointments in McCormick and Feinberg, leading interdisciplinary research in immunoengineering and biomaterials. Dr. Scott directs the PhD Admissions in Biomedical Engineering and co-directs the Multidisciplinary Training Program in Child and Adolescent Health (TL1) and the Therapeutics Design & Development Core of the George M. O’Brien Kidney Research Core Center (NUGoKidney).
His research focuses on applying nanotechnology and biomaterials to modulate the immune system for treating kidney disease, cancer, infectious diseases, glaucoma, vascular inflammation, and organ transplantation. Key innovations include nanocarrier-mediated drug delivery systems and biomimetic vaccines.
Dr. Scott earned a B.S. in Biomedical Engineering from Brown University (2002) and a Ph.D. from Washington University in St. Louis (2009). He completed postdoctoral research at EPFL in Switzerland under Professors Jeffrey Hubbell and Melody Swartz. His work has been recognized with awards including the NIH Director’s New Innovator Award (2015), NSF CAREER Award (2015), and AIMBE College of Fellows election (2022).
Scientific achievements include development of immunomodulatory nanoparticles for islet transplantation tolerance, Chagas disease combination nanotherapy, and mast cell-targeting therapies. His research group also explores novel vaccine platforms and nanostructure-enhanced targeting (NSET) strategies for inflammatory diseases.
Labs/Teams: Scott Research Group, collaborating with institutions like the Center for Human Immunobiology and Feinberg Cardiovascular and Renal Research Institute.
